* AASTROM Biosciences Inc., of Ann Arbor, Mich., named to itsboard of directors Horst Witzel, former chairman of Schering AG,Berlin, and Edward Wood, president of COBE BCT, Lakewood, Colo.* Biocryst Pharmaceuticals Inc., of Birmingham, Ala., named JohnHiggins director of corporate development.* Carrington Laboratories Inc., of Irving, Texas, appointed ClaudeaneWhaley director of consumer health.* Cryopharm Corp., of Pasadena, Calif., named Thomas Zuck, of theUniversity of Cincinnati Medical Center, to the board of directors.* Genentech Inc., of South San Francisco, named Louis Lavigne seniorvice president and chief financial officer and Stephen Juelsgaard vicepresident and general counsel.Signal Pharmaceuticals Inc., of San Diego, named the following to itsscientific advisory board: Inder Verma, of Salk Institute, La Jolla,Calif. (chairman); Fred Gage, of University of California, San Diego;Stephen Heinemann and Tony Hunter, both of Salk Institute, La Jolla;Michael Karin, of University of California, San Diego; K. BarrySharpless, of Scripps Research Institute, La Jolla; Charles Dinarello, ofTufts Medical School, Boston; Leonard Herzenberg, of StanfordUniversity School of Medicine; and Neal DeLuca, of University ofPittsburgh School of Medicine.* Synergen Inc., of Boulder, Colo., named Robert Hendrickson,formerly of Merck & Co. Inc., of Whitehouse Station, N.J., to theboard of directors.Syntex Corp., of Palo Alto, Calif., named the following Switzerland-based Roche Holdings Ltd. executives to the board of directors: ArminKessler, chief operating officer and head of the pharmaceuticalsdivision; Peter Simon, head of Pharma Operations; and KennethTaylor, president and managing director of Roche Products Ltd., of theU.K. Syntex also appointed Kenneth Taylor president.
(c) 1997 American Health Consultants. All rights reserved.